vs
Side-by-side financial comparison of DDC Enterprise Ltd (DDC) and EyePoint, Inc. (EYPT). Click either name above to swap in a different company.
DDC Enterprise Ltd is the larger business by last-quarter revenue ($5.4M vs $5.3M, roughly 1.0× EyePoint, Inc.). DDC Enterprise Ltd runs the higher net margin — -123.3% vs -1114.3%, a 991.0% gap on every dollar of revenue. DDC Enterprise Ltd produced more free cash flow last quarter ($-39.7M vs $-63.8M).
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems (MEMS) and nanotechnology to drug delivery.
DDC vs EYPT — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2025
| Metric | | |
|---|---|---|
| Revenue | $5.4M | $5.3M |
| Net Profit | $-6.7M | $-59.4M |
| Gross Margin | 31.4% | — |
| Operating Margin | -90.0% | -1166.8% |
| Net Margin | -123.3% | -1114.3% |
| Revenue YoY | — | -43.7% |
| Net Profit YoY | — | -92.8% |
| EPS (diluted) | — | $-0.85 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.4M | — | ||
| Q2 25 | $2.2M | $5.3M | ||
| Q1 25 | — | $24.5M | ||
| Q4 24 | — | $11.6M | ||
| Q3 24 | — | $10.5M | ||
| Q2 24 | — | $9.5M | ||
| Q1 24 | — | $11.7M | ||
| Q4 23 | — | $14.0M |
| Q4 25 | $-6.7M | — | ||
| Q2 25 | $715.3K | $-59.4M | ||
| Q1 25 | — | $-45.2M | ||
| Q4 24 | — | $-41.4M | ||
| Q3 24 | — | $-29.4M | ||
| Q2 24 | — | $-30.8M | ||
| Q1 24 | — | $-29.3M | ||
| Q4 23 | — | $-14.1M |
| Q4 25 | 31.4% | — | ||
| Q2 25 | 33.4% | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 93.0% | ||
| Q2 24 | — | 85.2% | ||
| Q1 24 | — | 93.5% | ||
| Q4 23 | — | — |
| Q4 25 | -90.0% | — | ||
| Q2 25 | 12.9% | -1166.8% | ||
| Q1 25 | — | -199.7% | ||
| Q4 24 | — | -390.4% | ||
| Q3 24 | — | -311.2% | ||
| Q2 24 | — | -364.5% | ||
| Q1 24 | — | -285.2% | ||
| Q4 23 | — | -116.6% |
| Q4 25 | -123.3% | — | ||
| Q2 25 | 33.2% | -1114.3% | ||
| Q1 25 | — | -184.8% | ||
| Q4 24 | — | -357.3% | ||
| Q3 24 | — | -279.0% | ||
| Q2 24 | — | -325.3% | ||
| Q1 24 | — | -250.6% | ||
| Q4 23 | — | -100.5% |
| Q4 25 | — | — | ||
| Q2 25 | — | $-0.85 | ||
| Q1 25 | — | $-0.65 | ||
| Q4 24 | — | $-0.65 | ||
| Q3 24 | — | $-0.54 | ||
| Q2 24 | — | $-0.58 | ||
| Q1 24 | — | $-0.55 | ||
| Q4 23 | — | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $21.7M | $255.7M |
| Total DebtLower is stronger | $610.8K | — |
| Stockholders' EquityBook value | $71.2M | $246.0M |
| Total Assets | $199.6M | $301.1M |
| Debt / EquityLower = less leverage | 0.01× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $21.7M | — | ||
| Q2 25 | $3.5M | $255.7M | ||
| Q1 25 | — | $318.2M | ||
| Q4 24 | — | $370.9M | ||
| Q3 24 | — | $253.8M | ||
| Q2 24 | — | $280.2M | ||
| Q1 24 | — | $299.3M | ||
| Q4 23 | — | $331.1M |
| Q4 25 | $610.8K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
| Q4 25 | $71.2M | — | ||
| Q2 25 | $3.9M | $246.0M | ||
| Q1 25 | — | $298.4M | ||
| Q4 24 | — | $336.5M | ||
| Q3 24 | — | $218.7M | ||
| Q2 24 | — | $228.3M | ||
| Q1 24 | — | $249.9M | ||
| Q4 23 | — | $266.3M |
| Q4 25 | $199.6M | — | ||
| Q2 25 | $12.4M | $301.1M | ||
| Q1 25 | — | $362.6M | ||
| Q4 24 | — | $418.5M | ||
| Q3 24 | — | $300.9M | ||
| Q2 24 | — | $324.2M | ||
| Q1 24 | — | $329.2M | ||
| Q4 23 | — | $355.2M |
| Q4 25 | 0.01× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-39.7M | $-62.6M |
| Free Cash FlowOCF − Capex | $-39.7M | $-63.8M |
| FCF MarginFCF / Revenue | -734.1% | -1196.5% |
| Capex IntensityCapex / Revenue | 0.1% | 22.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-194.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-39.7M | — | ||
| Q2 25 | — | $-62.6M | ||
| Q1 25 | — | $-53.1M | ||
| Q4 24 | — | $-35.8M | ||
| Q3 24 | — | $-39.0M | ||
| Q2 24 | — | $-20.2M | ||
| Q1 24 | — | $-31.2M | ||
| Q4 23 | — | $-23.1M |
| Q4 25 | $-39.7M | — | ||
| Q2 25 | — | $-63.8M | ||
| Q1 25 | — | $-53.4M | ||
| Q4 24 | — | $-36.2M | ||
| Q3 24 | — | $-40.6M | ||
| Q2 24 | — | $-21.1M | ||
| Q1 24 | — | $-32.4M | ||
| Q4 23 | — | $-24.0M |
| Q4 25 | -734.1% | — | ||
| Q2 25 | — | -1196.5% | ||
| Q1 25 | — | -218.4% | ||
| Q4 24 | — | -312.7% | ||
| Q3 24 | — | -385.8% | ||
| Q2 24 | — | -222.4% | ||
| Q1 24 | — | -277.0% | ||
| Q4 23 | — | -171.0% |
| Q4 25 | 0.1% | — | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | 1.1% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 15.0% | ||
| Q2 24 | — | 9.5% | ||
| Q1 24 | — | 10.2% | ||
| Q4 23 | — | 6.3% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
